The Heidenhain variant of Creutzfeldt-Jakob disease

Archives of Neurology

Volumn 56, Issue 1, 1999, Pages 55-61

  Kropp, Stefan ^a   Schulz Schaeffer, Walter J ^a   Finkenstaedt, Michael ^a,b   Riedemann, Christian ^a   Windl, Otto ^a   Steinhoff, Bernhard J ^a   Zerr, Inga ^a   Kretzschmar, Hans A ^a   Poser, Sigrid ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MR/CT Institute Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL GANGLION; CEREBRAL BLINDNESS; CODON; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE DURATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; METAMORPHOSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE; OCCIPITAL CORTEX; OCCIPITAL LOBE; PRIORITY JOURNAL; VISUAL FIELD DEFECT; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIONS; RETROSPECTIVE STUDIES;

EID: 0032951486     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.1.55     Document Type: Article

References (48)

1. Creutzfeldt HG. Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems (vorläufige Mitteilung). Z Ges Neurol Psychiatr. 1920;57:1-18.
2. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (Spastische Pseudosklerose-Encephalomyopathie mit disseminierten Degenerationsherden). Z Ges Neurol Psychiatr. 1921;64:147-228.
3. Windl O, Kretzschmar HA. Prion diseases. J Comp Neurol. In press.
4. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med, 1974;290:692-693.
5. Brown P, Preece MA, Will RG. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992;340:24-27.
6. Heckmann JG, Lang CJG, Druschky A, Brown P, Neundörfer B. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 1997;63:388-390.
7. Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E. Panencephalopathic type of Creutzfeldt-Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry. 1997;63:524-527.
8. Billette de Villemeur T, Deslys JP, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 1996;47: 690-695.
9. Prusiner SB. Novel proteinaceous infections particles cause scrapie. Science. 1982; 216:136-144.
10. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol. 1994;35:385-395.
11. Meyer W, Rosenbaum V, Schmidt B, et al. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol. 1991; 72:37-49.
12. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol. 1992;73:1025-1029.
13. Diringer H, Beekes M, Oberdieck U. The nature of the scrapie agent: the virus theory. Ann N Y Acad Sci. 1994;724:246-258.
14. Meyer A. Leigh D, Bagg CE. A rare presenile dementia associated with cortical blindness (Heidenhain's syndrome). J Neurol Neurosurg Psychiatry. 1954;17: 129-133.
15. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry. 1965; 28:350-351.
16. Gertz HJ, Stoltenberg G, Cruz-Sanchez F, Lafuente J, Schopol R. Der panenzephalitische Typ der Creutzfeldt-Jakob-Krankheit. Nervenarzt. 1988;9: 110-112.
17. Van Rossum A. Spastic pseudosclerosis (Creutzfeldt-Jakob disease). In: Vinken PJ, Bruyn GW, eds. Diseases of the Basal Ganglia. Amsterdam, the Netherlands: North Holland Publishing Co; 1968:726-760. Handbook of Clinical Neurology: vol 6.
18. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39:767-778.
19. Schulz-Schaeffer WJ, Giese A, Windl O, Kretzschmar HA. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol. 1996;15:353-357.
20. Heidenhain A, Klinische und anatomische Untersuchungen über eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium. Z Ges Neurol Psychiatr. 1929;118:49-114.
21. Hopf HC, Althaus HH, Sabunco S. "Typ Heidenhain" der subakuten spongiösen Encephalopathie (SSE) Creutzfeldt-Jakob. Z Neurol. 1974;206:149-156.
22. Schlote W. Subakute präsenle spongiforme Encephalopathie mit occipitalem Schwerpunkt und Rindenblindheit (Heidenhain-Syndrom). Arch Psychiatr Nervenkr. 1970;213:345-369.
23. Vargas ME, Kupersmitn MJ, Savino PJ, Petito F, Frohmann LP, Warren FA. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol. 1995;119:497-504.
24. Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuroophthalmol. 1989;9:242-246.
25. Bösch PL, Vass K. Subakute spongiöse Encephalopathie vom Typ Heidenhain. Nervenarzt. 1975;46:160-162.
26. Gálvez S, Dörr-Zegers O, Cartier L, Zur Klinik, Neuropathologie und Pathogeneseder Creutzfeldt-Jakob'schen Krankheit anhand von 40 gesicherten Fällen. Nervenarzt. 1982;53:132-140.
27. Masters CL, Harris JO, Gajdusek DC, Gibbs CJJ, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177-188.
28. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology. 1990;40:887-890.
29. Kitamoto T, Shin RW, Doh-ura K, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldf-Jakob disease. Am J Pathol. 1992;140:1285-1294.
30. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:913-920.
31. Nicholl D, Windl O, de Silva R, et al. Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene J Neurol Neurosurg Psychiatry. 1995;58:65-69.
32. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352: 340-342.
33. Orita M. Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymophisms. Proc Natl Acad Sci U S A. 1998;86:2766-2770.
34. Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet. 1996;98:259-264.
35. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996;53: 162-166.
36. Zerr I, Bodemer M, Räcker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 1995;345: 1609-1610.
37. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335:924-930.
38. De Silva R, Ironside JW, McArdle L, et al. Neuropathological phenotype and "prion protein" genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett. 1994;179:50-52.
39. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991;337:1441-1442.
40. Heinz A, Schmidt LG, Winterer G, Gerhard L, Przuntek H. Optische und taktile Halluzinose als klinischer Beginn einer Creutzfeldt-Jakob-Erkrankung. Nervenarzt. 1995;66:712-716.
41. Otto M, Stein M, Szudra A, et al. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 1997;244: 566-570.
42. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998; 43:32-40.
43. Schwaninger M, Winter R, Hacke W, et al. Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry. 1997;63:408-409.
44. 18F-Fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med 1996;10:131-134.
45. 123I-IMP SPECT brain scans for the early detection of site-specific abnormalities in Creutzfeldt-Jakob disease (Heidenhain type): a case study. Neuropsychobiology. 1994;29: 117-119.
46. Jibiki I, FukushimaT, Kobayashi K, Tatsuyuki A, Yamagushi N. Antagonizing correlation between periodic synchronous discharge and photically induced giant evoked responses in Creutzfeldt-Jakob disease (Heidenhain type): a case report. Psychiatry Clin Neurosci. 1995;49:87-90.
47. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease Radiology. 1996;199:793-798.
48. Staffen W, Trinka E, Iglseder B, Pilz P, Homann N, Ladurner G. Clinical and diagnostic findings in a patient with Creutzfeldt-Jakob disease (type Heidenhain). J Neuroimaging. 1997;7:50-54.